CHRIS P. MILLER obtained his PhD in organic chemistry fromthe University of Pittsburgh and is a magna cum laude graduate ofthe Temple University Beasley School of Law. Dr. Miller has over adecade of research experience as a medicinal chemist in thepharmaceutical industry and has worked as an associate at a lawfirm as well as served as in-house patent counsel in big pharma andthe biotech industry. Dr. Miller is licensed to practice law beforethe state bar of Pennsylvania and the United States Patent andTrademark Office. He currently is practicing both medicinalchemistry and patent law in the Boston area. MARK J. EVANS obtained his PhD from NorthwesternUniversity and his MBA from Penn State University; has fifteenyears of pharmaceutical industry experience in the development ofboth small molecule and protein therapeutics at WyethPharmaceuticals and Alexion Pharmaceuticals; and currently works inregulatory affairs in the Philadelphia area.